Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation

Endocrinology

Volumn 141, Issue 1, 2000, Pages 118-126

  Melck, Dominique ^a   De Petrocellis, Luciano ^b   Orlando, Pierangelo ^c   Bisogno, Tiziana ^a   Laezza, Chiara ^d   Bifulco, Maurizio ^d   Marzo, Vincenzo D I ^a,c  

^a Istituto per la Chimica di Molecole di Interesse Biologico   (Italy)

^b CNR   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DEXANABINOL; NERVE GROWTH FACTOR RECEPTOR; PALMIDROL; PROLACTIN RECEPTOR; RIMONABANT;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0034465259     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.1.7239     Document Type: Article

References (43)

1. Pharmacology of cannabinoid CB1 and CB2 receptors
2. Isolation and structure of a brain costituent that binds to the cannabinoid receptor
3. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
4. 2-Arachidonoyl-glycerol: A possible endogenous cannabinoid receptor ligand in brain
5. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
6. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
7. Inhibition of the cAMP signaling cascade via cannabinoid receptors: A putative mechanism of immune modulation by cannabinoid compounds
8. Formarion of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: Proposed role in neurotoxicity
9. Cardiovascular actions of cannabinoids and their generation during shock
10. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion
11. Cannabinoid transmission and pain perception
12. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia
13. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
14. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop
15. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
16. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors
17. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells: Implications for cell proliferation and differentiation
18. Unsatttrated long chain N-acyl-vanillyl-amides (N-AVAMs). Vanilloid receptor ligands that inhibit anandamide facilitated transport and bind to CB1 cannabinoid receptors
19. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate
20. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells
21. New class of potent ligands for the human peripheral cannabinoid receptor
22. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
23. Molecular biology of the cannabinoid receptor
24. Molecular characterization of a peripheral receptor for cannabinoids
25. Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: Immunochemical characterization by fusion protein antibodies
26. Failure of cannabinoid compounds to stimulate estrogen receptors
27. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate
28. Neurotrophic factors in prostate and prostatic cancer
29. The saga of the nerve growth factor
30. Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death
31. Arachidonate-phospholipid remodeling and cell proliferation
32. Increased expression of prolactin gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues
33. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines
34. Prolactin signaling in mammary gland development
35. Prolactin, growth hormone and the immune system in humans
36. Nerve growth factor: From neurotrophin to neurokine
37. Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland
38. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
39. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages
40. Trick or treat from food endocannabinoids?
41. Expression of functional trk protooncogene in human monocytes
42. Stimulation of adenylyl cyclase and induction of brain-derived neurotrophic factor and TrkB mRNA by NKH477, a novel and potent forskolin derivative
43. Pancreatic β cells synthesize and secrete nerve growth factor